NCT00463801View on ClinicalTrials.gov

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

PHASE4TerminatedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Conditions
Staphylococcal Skin Infections
Interventions
DRUG

Daptomycin

Trial Locations (2)

Unknown

Novartis Italy, Novartis Italy

Novartis Italy, Saronno

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY